Core Viewpoint - A class action lawsuit has been filed against Ardent Health, Inc. and certain senior executives for securities fraud following a significant stock drop due to potential violations of federal securities laws [1]. Company Overview - Ardent Health operates acute care hospitals and other healthcare facilities, with a critical focus on the collection of accounts receivable [4]. Allegations - The lawsuit claims that Ardent Health misrepresented its process for determining the collectability of accounts receivable, stating it relied on "detailed reviews of historical collections," while in reality, it used a "180-day cliff" method, leading to inflated accounts receivable figures [4]. - This misrepresentation is alleged to violate federal securities laws [4]. Stock Performance - On November 12, 2025, Ardent Health disclosed a $43 million revenue decrease for the quarter and a $54 million increase in professional liability reserves, resulting in a stock price drop of $4.75 per share, or over 33%, from $14.05 to $9.30 [5]. Legal Proceedings - Investors have until March 9, 2026, to request to lead the case in the U.S. District Court for the Middle District of Tennessee, under the caption Postiwala v. Ardent Health, Inc., et al. [3].
ARDT SHAREHOLDERS: Ardent Health Accused of Misrepresentations about the Collectability of its Receivables in BFA Law's Securities Class Action – Investors Urged to Contact the Firm